HC Wainwright Reaffirms Buy Rating for Cardiol Therapeutics (NASDAQ:CRDL)
HC Wainwright restated their buy rating on shares of Cardiol Therapeutics (NASDAQ:CRDL – Free Report) in a research note released on Wednesday,Benzinga reports. They currently have a $9.00 price target on the stock. CRDL has been the topic of a number of other research reports. Rodman & Renshaw initiated coverage on shares of Cardiol Therapeutics […]
HC Wainwright restated their buy rating on shares of Cardiol Therapeutics (NASDAQ:CRDL – Free Report) in a research note released on Wednesday,Benzinga reports. They currently have a $9.00 price target on the stock. CRDL has been the topic of a number of other research reports. Rodman & Renshaw initiated coverage on shares of Cardiol Therapeutics […]